Multiple Sclerosis
A Areas medical research research area page covering state of the field, key trials running, recent readouts and what is close to approval, alongside the 7
Christina Applegate's MS Misdiagnosis Highlights Diagnostic Advances
Christina Applegate's five-year misdiagnosis of multiple sclerosis shows persistent challenges in neurology, even as modern tools like the McDonald...
FDA Grants Priority Review for Roche's MS Pill Fenebrutinib
The FDA has accepted Roche's application for fenebrutinib, an oral BTK inhibitor for multiple sclerosis, initiating a six-month priority review.
AbbVie's dual-acting myeloma drug etentamig meets Phase 3 endpoint
AbbVie reported that its bispecific antibody etentamig met the primary endpoint in a Phase 3 trial for multiple myeloma.
Novartis, Bristol Myers pause autoimmune CAR-T trials
Novartis and Bristol Myers Squibb have paused multiple trials of their CAR-T therapies for autoimmune diseases following serious safety incidents.
STAT Launches Initiative to Address Trust in Science
STAT introduces a new initiative focused on trust in science, hiring Nicholas Florko as a dedicated reporter to explore misinformation, its origins...
FDA Clears Bristol Myers Squibb's Oral Multiple Myeloma Therapy, Introducing First-in-Class Agent
The U.S. FDA has approved Bristol Myers Squibb’s oral drug iberdomide, marketed as Zenbexus, for use with daratumumab and dexamethasone in patients...
FDA Approves Bristol Myers Squibb’s Zenbexus for Advanced Multiple Myeloma, Marking Debut of New Drug Class
The U.S. FDA has approved Zenbexus, Bristol Myers Squibb’s oral treatment for advanced multiple myeloma, introducing a new class of blood cancer...